Koers OUTLOOK THERAPEUTICS, INC. Nasdaq
Aandelen
US68235M1053
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | 9,53 mln. 8,76 mln. | Marktkapitalisatie | 198 mln. 182 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -121 mln. -111 mln. | Nettowinst (verlies) 2025 * | -64 mln. -58,82 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 20,7 x |
K/w-verhouding 2024 * |
-1,68
x | K/w-verhouding 2025 * |
-3,79
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 63,78% |
Recentste transcriptie over OUTLOOK THERAPEUTICS, INC.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13-04-18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11-12-15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,84% | 46,56 mld. | |
+45,49% | 41,67 mld. | |
-0,29% | 41,16 mld. | |
+34,09% | 32,4 mld. | |
+20,73% | 28,18 mld. | |
-6,35% | 28,1 mld. | |
+49,30% | 14,52 mld. | |
+48,01% | 13,74 mld. | |
+1,96% | 12,17 mld. |